36 filings
6-K
PPBT
Purple Biotech Ltd
23 Dec 19
Current report (foreign)
4:20pm
6-K
PPBT
Purple Biotech Ltd
19 Nov 19
Report of Foreign Private Issuer
4:31pm
6-K
PPBT
Purple Biotech Ltd
12 Nov 19
Current report (foreign)
4:26pm
6-K
PPBT
Purple Biotech Ltd
18 Oct 19
Thank you Corporate Presentation October 2019
4:09pm
6-K
PPBT
Purple Biotech Ltd
11 Oct 19
Kitov Pharma Announces Amended Marketing and Distribution Agreement with Coeptis and Provides Update on the Upcoming Launch of ConsensiTMin the U.S
9:02am
6-K
zi6g73gziai
2 Oct 19
Kitov Pharma Appoints Eric K. Rowinsky, M.D., as Chairman of its Board
8:49am
6-K
nzuefst9
10 Sep 19
Thank you Corporate Presentation September 2019
9:32am
6-K
1c9 id29rqc
9 Sep 19
Kitov Pharma Presents Newly Released Data for NT-219 in Reversing Pancreatic Cancer Drug Resistance
8:40am
6-K
h1b8bdtscs xu2
3 Sep 19
Kitov Pharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference
8:23am
6-K
1b69ng
29 Aug 19
Report of Foreign Private Issuer
8:30am
6-K
zkw88mifoy1g8256vn
20 Aug 19
Kitov Pharma Announces Significant Progress in Closing of FameWave Acquisition Deal
6:04am
6-K
uprc3 bgm0od9ty
14 Aug 19
Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli Securities Authority
12:00am
6-K
5yidq3raf khz0
13 Aug 19
Current report (foreign)
5:01pm
6-K
d5pojlf5m5ds0
8 Aug 19
Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update
4:32pm
6-K
l566xr5utwa0gim7
12 Jul 19
Kitov Receives Nasdaq Notification Regarding Minimum Bid Requirements
5:12pm
6-K
j8oe27wk
2 Jul 19
Report of Foreign Private Issuer
4:31pm
6-K
65p2tunr889wo72b
27 Jun 19
Kitov Successfully Completes IND-enabling Studies to advance NT219 for the Treatment of Patients with Recurrent or Metastatic Head and Neck Cancers
7:35am
6-K
0pc99ljille33ga
16 May 19
Report of Foreign Private Issuer
7:30am
6-K
pvuyi1kjs
10 May 19
Report of Foreign Private Issuer
4:02pm
6-K
4o82vci1 tfq
9 May 19
Kitov to Present Clinical Development Plan for Oncology Candidate NT-219 at the 18th MIXiii-BIOMED Conference
4:05pm